Salvatore Nappa

1.1k total citations
22 papers, 794 citations indexed

About

Salvatore Nappa is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Salvatore Nappa has authored 22 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Epidemiology and 4 papers in Hepatology. Recurrent topics in Salvatore Nappa's work include HIV/AIDS drug development and treatment (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and HIV/AIDS Research and Interventions (3 papers). Salvatore Nappa is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and HIV/AIDS Research and Interventions (3 papers). Salvatore Nappa collaborates with scholars based in Italy, United Kingdom and United States. Salvatore Nappa's co-authors include Guglielmo Borgia, Rita Murri, Andrea Antinori, Adriana Ammassari, Patrizio De Longis, Paola Piano, Laura Ravasio, Giuseppe Ippolito, Miriam Lichtner and Patrizio Pezzotti and has published in prestigious journals such as Hepatology, Medicine and Atherosclerosis.

In The Last Decade

Salvatore Nappa

22 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salvatore Nappa Italy 10 428 210 202 180 93 22 794
John Rublein United States 10 296 0.7× 117 0.6× 104 0.5× 128 0.7× 23 0.2× 15 502
Ian R. McNicholl United States 16 604 1.4× 379 1.8× 310 1.5× 240 1.3× 33 0.4× 31 942
Rebecca Lodwick United Kingdom 14 699 1.6× 309 1.5× 380 1.9× 379 2.1× 17 0.2× 22 1.1k
Christine U. Oramasionwu United States 15 264 0.6× 102 0.5× 295 1.5× 33 0.2× 64 0.7× 36 776
Guido E.L. van den Berk Netherlands 8 243 0.6× 124 0.6× 303 1.5× 110 0.6× 66 0.7× 13 550
Roger Bedimo United States 14 365 0.9× 122 0.6× 311 1.5× 57 0.3× 30 0.3× 25 638
Marcelo Wolff Chile 16 597 1.4× 164 0.8× 397 2.0× 266 1.5× 24 0.3× 64 896
Marianna Menozzi Italy 17 974 2.3× 1.2k 5.7× 553 2.7× 498 2.8× 26 0.3× 46 1.7k
Matilde Sánchez‐Conde Spain 20 610 1.4× 317 1.5× 635 3.1× 262 1.5× 357 3.8× 75 1.3k
Alice Thornton United States 17 388 0.9× 73 0.3× 444 2.2× 81 0.5× 26 0.3× 51 861

Countries citing papers authored by Salvatore Nappa

Since Specialization
Citations

This map shows the geographic impact of Salvatore Nappa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvatore Nappa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvatore Nappa more than expected).

Fields of papers citing papers by Salvatore Nappa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvatore Nappa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvatore Nappa. The network helps show where Salvatore Nappa may publish in the future.

Co-authorship network of co-authors of Salvatore Nappa

This figure shows the co-authorship network connecting the top 25 collaborators of Salvatore Nappa. A scholar is included among the top collaborators of Salvatore Nappa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvatore Nappa. Salvatore Nappa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buonomo, Antonio Riccardo, Riccardo Scotto, Carmine Coppola, et al.. (2020). Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence. Medicine. 99(6). e18948–e18948. 6 indexed citations
2.
Buonomo, Antonio Riccardo, Riccardo Scotto, Salvatore Nappa, et al.. (2018). The role of curcumin in liver diseases. Archives of Medical Science. 15(6). 1608–1620. 26 indexed citations
3.
Buonomo, Antonio Riccardo, Riccardo Scotto, Emanuela Zappulo, et al.. (2018). Severe Vitamin D Deficiency Increases Mortality Among Patients With Liver Cirrhosis Regardless of the Presence of HCC. In Vivo. 33(1). 177–182. 19 indexed citations
4.
Maraolo, Alberto Enrico, Ivan Gentile, Biagio Pinchera, Salvatore Nappa, & Guglielmo Borgia. (2018). Current and emerging pharmacotherapy for the treatment of bacterial peritonitis. Expert Opinion on Pharmacotherapy. 19(12). 1317–1325. 9 indexed citations
5.
Borgia, Guglielmo, Alberto Enrico Maraolo, Salvatore Nappa, Ivan Gentile, & Antonio Riccardo Buonomo. (2017). NS5B polymerase inhibitors in phase II clinical trials for HCV infection. Expert Opinion on Investigational Drugs. 27(3). 243–250. 8 indexed citations
6.
Cozzolino, Immacolata, Salvatore Nappa, Marco Picardi, et al.. (2009). Clonal B‐cell population in a reactive lymph node in acquired immunodeficiency syndrome. Diagnostic Cytopathology. 37(12). 910–914. 31 indexed citations
7.
Foggia, Maria, et al.. (2008). Tenofovir Disoproxil Fumarate in the Clinical Practice: An Overview. 7(4). 285–295. 3 indexed citations
8.
Oliviero, Ugo, Maria Foggia, Giorgio Bosso, et al.. (2008). Human immunodeficiency virus per se exerts atherogenic effects. Atherosclerosis. 204(2). 586–589. 75 indexed citations
9.
Murri, Rita, Andrea Antinori, Adriana Ammassari, et al.. (2002). Physician Estimates of Adherence and the Patient-Physician Relationship as a Setting to Improve Adherence to Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31. S158–S162. 59 indexed citations
10.
Ammassari, Adriana, Rita Murri, Patrizio Pezzotti, et al.. (2001). Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 28(5). 445–449. 386 indexed citations
11.
Ammassari, Adriana, Rita Murri, Patrizio Pezzotti, et al.. (2001). Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 28(5). 445–449. 29 indexed citations
12.
Piazza, M, et al.. (1995). HCV-RNA survival as detected by PCR in the environment.. PubMed. 70(5-6). 167–70. 8 indexed citations
13.
Piazza, Marcello, et al.. (1995). Detection of hepatitis C virus‐RNA by polymerase chain reaction in dental surgeries. Journal of Medical Virology. 45(1). 40–42. 58 indexed citations
14.
Piazza, M, et al.. (1987). Contamination by hepatitis B surface antigen in dental surgeries.. BMJ. 295(6596). 473–474. 16 indexed citations
15.
Caterina, Maurizio De, Roberto Grassi, Guglielmo Borgia, et al.. (1987). Morphological and functional abnormalities in platelets exposedin vitro to ioglicinic acid, a new ionic contrast medium. La Ricerca in Clinica e in Laboratorio. 17(2). 143–147. 1 indexed citations
16.
Piazza, M, Guglielmo Borgia, Salvatore Nappa, et al.. (1987). [HBsAg (hepatitis B virus surface antigen) contamination in the dental environment].. PubMed. 36(12). 903–7. 1 indexed citations
17.
Piazza, Marcello, et al.. (1985). The Effect of 3–Palmitoyl–(+)–Catechin on Kupffer Cells in Guinea Pig Liver. Hepatology. 5(5). 867–869. 6 indexed citations
18.
Borgia, Guglielmo, et al.. (1985). Tuberculous mesenteric lymphadenitis clinically presenting as abdominal mass: CT and sonographic findings. Journal of Clinical Ultrasound. 13(7). 491–493. 4 indexed citations
19.
Borgia, Guglielmo, et al.. (1984). Pancreatic plasmacytoma: an unusual cause of obstructive jaundice.. PubMed. 108(10). 773–4. 4 indexed citations
20.
Borgia, Guglielmo, et al.. (1982). [Ultrastructural changes in hepatocytes of mice treated with heroin].. PubMed. 58(16). 1075–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Rublein Breakdown of academic impact, for papers by Ian R. McNicholl Breakdown of academic impact, for papers by Rebecca Lodwick Breakdown of academic impact, for papers by Christine U. Oramasionwu Breakdown of academic impact, for papers by Guido E.L. van den Berk Breakdown of academic impact, for papers by Roger Bedimo Breakdown of academic impact, for papers by Marcelo Wolff Breakdown of academic impact, for papers by Marianna Menozzi Breakdown of academic impact, for papers by Matilde Sánchez‐Conde Breakdown of academic impact, for papers by Alice Thornton
Rankless by CCL
2026